AIkido Pharma (AIKI) Competitors $6.25 -0.22 (-3.40%) As of 08/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, DKDCA, CLYM, PROF, MDXH, MBOT, MOLN, FATE, CGEN, and IOBTShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Climb Bio (CLYM), Profound Medical (PROF), MDxHealth (MDXH), Microbot Medical (MBOT), Molecular Partners (MOLN), Fate Therapeutics (FATE), Compugen (CGEN), and IO Biotech (IOBT). AIkido Pharma vs. Its Competitors Luna Innovations Data Knights Acquisition Climb Bio Profound Medical MDxHealth Microbot Medical Molecular Partners Fate Therapeutics Compugen IO Biotech AIkido Pharma (NASDAQ:AIKI) and Luna Innovations (NASDAQ:LUNA) are both small-cap commercial physical research industry companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Which has more risk and volatility, AIKI or LUNA? AIkido Pharma has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 2.01, indicating that its share price is 101% more volatile than the S&P 500. Is AIKI or LUNA more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Luna Innovations N/A N/A N/A Does the media prefer AIKI or LUNA? In the previous week, AIkido Pharma's average media sentiment score of 0.00 equaled Luna Innovations'average media sentiment score. Company Overall Sentiment AIkido Pharma Neutral Luna Innovations Neutral Which has higher earnings and valuation, AIKI or LUNA? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido PharmaN/AN/A-$7.17M-$3.88-1.61Luna Innovations$116.61M0.26$9.28MN/AN/A Do insiders & institutionals believe in AIKI or LUNA? 10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 87.5% of Luna Innovations shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by insiders. Comparatively, 7.6% of Luna Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryLuna Innovations beats AIkido Pharma on 6 of the 7 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.28M$22.60M$5.69B$9.86BDividend YieldN/AN/A3.99%4.02%P/E Ratio-1.61N/A79.6626.58Price / SalesN/A0.26536.52112.00Price / CashN/A57.2337.7059.65Price / Book0.320.3210.576.59Net Income-$7.17M-$525K$3.27B$265.83M7 Day Performance12.41%9.97%0.61%0.18%1 Month Performance22.31%23.88%5.43%2.13%1 Year Performance293.11%69.83%50.37%21.07% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$6.25-3.4%N/A+306.9%$34.28MN/A-1.614High Trading VolumeLUNALuna Innovations0.1078 of 5 stars$1.00+29.9%N/A-61.9%$33.96M$116.61M0.00390Gap DownDKDCAData Knights AcquisitionN/A$0.64-33.0%N/A-21.9%$3.32MN/A-3.382Gap DownHigh Trading VolumeCLYMClimb Bio3.3428 of 5 stars$2.02-4.3%$9.00+345.5%N/A$142.98MN/A-2.899Gap UpPROFProfound Medical1.7959 of 5 stars$4.58-3.6%$11.00+140.2%-49.8%$142.75M$10.68M-3.14150Gap DownMDXHMDxHealth2.5651 of 5 stars$2.90-2.7%$7.00+141.4%+21.0%$140.92M$90.05M-3.30300Positive NewsMBOTMicrobot Medical1.3408 of 5 stars$3.09+0.3%$9.00+191.3%+322.3%$140.28MN/A-5.3320Gap UpMOLNMolecular Partners1.7585 of 5 stars$3.60+3.7%$12.00+233.3%-41.5%$140.10M$5.65M-1.87180Earnings ReportAnalyst RevisionFATEFate Therapeutics3.8491 of 5 stars$1.14-5.0%$3.58+214.3%-69.2%$138.40M$13.63M-0.79550CGENCompugen1.865 of 5 stars$1.46-5.8%$4.00+174.0%-26.3%$138.32M$27.86M-6.6470News CoveragePositive NewsIOBTIO Biotech3.0681 of 5 stars$2.05-1.9%$8.67+322.8%+0.0%$137.69MN/A-1.3030 Related Companies and Tools Related Companies Luna Innovations Alternatives Data Knights Acquisition Alternatives Climb Bio Alternatives Profound Medical Alternatives MDxHealth Alternatives Microbot Medical Alternatives Molecular Partners Alternatives Fate Therapeutics Alternatives Compugen Alternatives IO Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access